Ebola trial stopped early as Regeneron, Ridgeback therapies cut death risk; Merck inks deal to test Keytruda with Oncologie's antibody
→ As armed rebels conflict with containment efforts to thwart the deadly Ebola virus in the Congo, a trial testing the viability of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
